143
Participants
Start Date
November 8, 2017
Primary Completion Date
April 19, 2023
Study Completion Date
April 19, 2023
chemotherapy
Dexamethasone and/or vincristine and/or pegasparaginase OR cytarabine and/or etoposide and/or pegasparaginase; tyrosine kinase inhibitor; cytarabine OR azacitidine OR decitabine; rituximab and/or dexamethasone and/or vincristine; cyclophosphamide and/or topotecan
venetoclax
Oral tablet for participants; Tablet for oral suspension (participants who cannot swallow a tablet)
Sydney Children's Hospital /ID# 163148, Randwick
Royal Children's Hospital /ID# 163104, Parkville
Queensland Children's Hospital /ID# 163146, South Brisbane
Women and Childrens Hospital /ID# 163147, North Adelaide
Kinderspital Zurich - Eleonorenstiftung /ID# 163037, Zurich
Charite Universitaetsklinikum Berlin - Campus Virchow /ID# 161730, Berlin
AP-HM - Hopital de la Timone /ID# 161465, Marseille
Children's Hospital of Philadelphia /ID# 163445, Philadelphia
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 161729, Kiel
Children's Healthcare of Atlan /ID# 161552, Atlanta
CHU Toulouse - Hôpital des enfants /ID# 163727, Toulouse
St Jude Children's Research Hospital /ID# 163447, Memphis
Universitaetsklinikum Essen /ID# 164207, Essen
Cincinnati Children's Hospital /ID# 161550, Cincinnati
Centre Leon Berard /ID# 163707, Lyon
AP-HP - Hopital Armand-Trousseau /ID# 163728, Paris
Robert Debre Hopital, FR /ID# 161464, Paris
Universitaetsklinikum Freiburg /ID# 164206, Freiburg im Breisgau
Children's Hospital Colorado /ID# 161551, Aurora
Primary Children's /ID# 164399, Salt Lake City
Seattle Children's Hospital /ID# 163459, Seattle
Univ California, San Francisco /ID# 163460, San Francisco
Dana-Farber Cancer Institute /ID# 163440, Boston
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 163444, New York
Medical College of Wisconsin /ID# 163461, Milwaukee
Hospital for Sick Children /ID# 163726, Toronto
CHU Sainte-Justine /ID# 163725, Montreal
Erasmus MC - Sophia /ID# 161579, Rotterdam
Prinses Maxima Centrum /ID# 162670, Utrecht
Great Ormond Street Hospital for Children /ID# 169238, London
The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 162938, Newcastle upon Tyne
Lead Sponsor
Roche-Genentech
INDUSTRY
AbbVie
INDUSTRY